ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 137 filers reported holding ANAPTYSBIO INC in Q4 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $510,280 | -8.8% | 28,412 | +3.3% | 0.00% | – |
| Q2 2023 | $559,493 | -88.0% | 27,507 | -87.1% | 0.00% | -100.0% |
| Q1 2023 | $4,651,000 | +70008.5% | 213,741 | -0.2% | 0.00% | 0.0% |
| Q4 2022 | $6,634 | -99.9% | 214,084 | -4.7% | 0.00% | 0.0% |
| Q3 2022 | $5,733,000 | +22.0% | 224,729 | -2.9% | 0.00% | 0.0% |
| Q2 2022 | $4,699,000 | -19.0% | 231,444 | -1.2% | 0.00% | 0.0% |
| Q1 2022 | $5,798,000 | -29.4% | 234,361 | -0.8% | 0.00% | 0.0% |
| Q4 2021 | $8,213,000 | +23.4% | 236,338 | -3.6% | 0.00% | 0.0% |
| Q3 2021 | $6,653,000 | -16.3% | 245,270 | -20.0% | 0.00% | 0.0% |
| Q2 2021 | $7,951,000 | +14.2% | 306,661 | -5.1% | 0.00% | 0.0% |
| Q1 2021 | $6,962,000 | +7.4% | 323,080 | +7.1% | 0.00% | 0.0% |
| Q4 2020 | $6,483,000 | +71.1% | 301,556 | +17.0% | 0.00% | 0.0% |
| Q3 2020 | $3,790,000 | -39.1% | 257,656 | -7.4% | 0.00% | 0.0% |
| Q2 2020 | $6,219,000 | +41.4% | 278,376 | -10.6% | 0.00% | 0.0% |
| Q1 2020 | $4,397,000 | -36.1% | 311,211 | -26.5% | 0.00% | 0.0% |
| Q4 2019 | $6,880,000 | +235.8% | 423,338 | +623.1% | 0.00% | – |
| Q3 2019 | $2,049,000 | -33.0% | 58,542 | +4.4% | 0.00% | -100.0% |
| Q2 2019 | $3,058,000 | -23.3% | 56,072 | +2.7% | 0.00% | 0.0% |
| Q1 2019 | $3,987,000 | +14.3% | 54,584 | -0.2% | 0.00% | 0.0% |
| Q4 2018 | $3,487,000 | -33.2% | 54,668 | +4.5% | 0.00% | 0.0% |
| Q3 2018 | $5,221,000 | -42.1% | 52,326 | -58.8% | 0.00% | -50.0% |
| Q2 2018 | $9,016,000 | +69.3% | 126,901 | +148.0% | 0.00% | +100.0% |
| Q1 2018 | $5,325,000 | -25.2% | 51,167 | -27.6% | 0.00% | 0.0% |
| Q4 2017 | $7,119,000 | +11.9% | 70,687 | -61.4% | 0.00% | 0.0% |
| Q3 2017 | $6,363,000 | +350.0% | 183,319 | +210.2% | 0.00% | – |
| Q2 2017 | $1,414,000 | -63.3% | 59,100 | -57.4% | 0.00% | -100.0% |
| Q1 2017 | $3,851,000 | – | 138,738 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $65,033,000 | 13.01% |
| EcoR1 Capital, LLC | 7,521,024 | $186,070,000 | 5.82% |
| GREAT POINT PARTNERS LLC | 700,000 | $17,318,000 | 4.18% |
| Frazier Life Sciences Management, L.P. | 899,700 | $22,259,000 | 1.90% |
| Boxer Capital, LLC | 1,300,000 | $32,162,000 | 1.65% |
| Logos Global Management LP | 300,000 | $7,422,000 | 0.96% |
| Deep Track Capital, LP | 558,782 | $13,824,000 | 0.89% |
| Palo Alto Investors LP | 431,024 | $10,664,000 | 0.82% |
| TCG Crossover Management, LLC | 58,515 | $1,448,000 | 0.58% |
| Rock Springs Capital Management LP | 563,300 | $13,936,000 | 0.35% |